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Balanced Electrolyte Solutions or Normal Saline? Resuscitative
Fluid Administration Practice in Swiss Pediatric Acute Care
A Cross-Sectional Study
Jasmin L. Huber,* Steffen Berger, MD,† and Ruth M. Löllgen, MD‡
Introduction: The ideal asanguineous intravenous fluid for volume re-
suscitation in children is controversially debated and clinical practice
guidelines are scarce. Administration of large amounts of normal saline
has been associated with complications including hyperchloremic acidosis,
dysnatremia, neurologic damage, and fatality.
Aim: We examined the current practice of intravenous fluid and blood
product administration in acutely ill and injured children among pediatric
acute care physicians in Switzerland.
Methods: For this descriptive, cross-sectional study, pediatric emergency
departments, pediatric and neonatal intensive care units were surveyed by
means of an online questionnaire.
Results: Sixty of 66 departments and 47 of 87 participants returned the
survey. Normal saline (NS) was most commonly administered (n = 42/
46, 91.3%) and twice as many times as balanced electrolyte solutions
(n = 20/46, 43.5%). Themean fluid volumes ranged from 7.9 to 19.1mL/kg.
Hypertonic saline/NS were selected most often for shock with severe head
injury. Half of participants administered colloids (48.9%). Packed red
blood cells (97.7%) and fresh frozen plasma (88.4%) were most frequently
given blood products.
Conclusion: There is a distinct practice variation in intravenous fluid
and blood product administration in children in Switzerland. Although
NS is most frequently given, we observed a trend toward the use of bal-
anced electrolyte solutions. Prospective studies are warranted to com-
pare NS with balanced electrolyte solution (BES) in the pediatric acute
care setting. We suggest that pediatric fluid administration guidelines
and mass transfusion protocols are implemented to standardize this frequent
intervention and minimize complications.
Key Words: balanced electrolyte solutions, intravenous fluids,
normal saline, resuscitation, shock, trauma
(Pediatr Emer Care 2019;00: 00–00)
WHAT IS ALREADY KNOWN ON THIS SUBJECT
There is growing evidence that BES might be preferable to
NS for fluid resuscitation in the acute setting. However, these data
mainly stem from adult studies and current intravenous fluid ad-
ministration practice in pediatric patients is inconsistent and not
evidence based.
WHAT THIS STUDY ADDS
Our study reveals a distinct clinical practice variation in intra-
venous fluid resuscitation among pediatric acute care physicians
in Switzerland. The observed overall trend toward the use of
BES is in contrast to a rift between West Switzerland, still prefer-
ring NS, and East Switzerland, tending to use BES. In combina-
tion with dissention on this topic in the literature and lack of
evidence in children, our findings emphasize the need for pro-
spective studies determining the benefits and adverse effects of
various crystalloids in pediatric patients.
INTRODUCTION
Intravenous (IV) fluid administration is a lifesaving corner-
stone of therapy in critically ill children but may evoke metabolic
complications including dysnatremia, hyperchloremic metabolic
acidosis, hyponatremic encephalopathy, permanent neurological
damage, and death.1 The ideal asanguineous IV fluid is controver-
sially debated. Isotonic fluids protect against dysnatremia1 and
therefore are the fluid of choice for initial volume resuscitation.1–3
Normal saline (NS) is most frequently used for fluid resuscita-
tion.2,4 However, by using large volumes of NS containing
supraphysiologic chloride (Cl) contents (154 mEq/L), plasma Cl
levels may rise excessively and induce hyperchloremic metabolic
acidosis.2,5 Polyelectrolyte solutions (Lactated Ringer's [LR],
Ringer acetate [RA]) contain more physiological Cl contents
resembling human plasma (94–111 mEq/L), 109 mEq/L and
98 mEq/L, respectively, and are alkalinizing agents.5 Pediatric
studies comparing NS to balanced electrolyte solutions (BES)
are scarce and contradictory.6–8 Recently, published results sug-
gest that fluid resuscitation with BES instead of NS in critically
ill adult patients reduces adverse kidney events and fatality and
increases hospital-free days.9 “Damage control resuscitation” in
pediatric trauma advocates smaller volume resuscitation and per-
missive hypotension for the benefit of reducing fluid extravasa-
tion, cerebral edema, raised intracranial pressure, and damaged
microvasculature.10 Only few pediatric IV fluid clinical practice
guidelines (CPG)3 and massive transfusion protocols (MTP) ex-
ist and plasma transfusion guidelines are not standardized.11,12
We assessed the current practice of IV fluid resuscitation and
transfusion standards in critically ill children among pediatric
emergency medicine physicians, pediatric intensivists, and neo-
natologists in Switzerland.
METHODS
Study and Survey Design
We composed aweb-based questionnaire comprising 27 ques-
tions on IV fluid, blood product (BP) and tranexamic acid (TXA)
administration, and use ofMTPs (see Supplemental Digital Content
1, http://links.lww.com/PEC/A407). We translated the survey into
standard German (63% of Swiss residents are native speakers),
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French (22.7%), and English (for Italian [8.4%] and Romansh
[0.6%] native speakers), validated it linguistically (see Supplemen-
tal Digital Content 2, http://links.lww.com/PEC/A408), and format-
ted it using Survey Monkey.
Study Population
We surveyed all Swiss pediatric intensive care units (PICUs,
n = 9), pediatric emergency departments (PEDs, n = 28), neonatal
intensive care (NICU, n = 9), and neonatal units (NUs, n = 20) on
IV fluid administration and transfusion strategies, using the
foederatio medicorum helveticorum register of educational hospi-
tals for reference (http://www.siwf-register.ch). Level III, IIb, and
IIa NICUs, caring for neonates aged≥24 0/7weeks,≥32 0/7weeks,
and ≥34 0/7 weeks of gestational age, respectively, were in-
cluded, and level 1 NUs were excluded (http://www.neonet.ch).
We dispatched the questionnaire by e-mail to 1 senior physician
of each department. Nonresponders received 2 two-weekly re-
minders by e-mail, and if still unanswered, questionnaires were
redirected to an alternate physician of the same department.
Statistical Analysis
We examined the quantitative questions using SPSS statis-
tics, Version 24. For yes/no questions, the proportion of physi-
cians responding yes/no was presented as percentage. We used
the Fisher exact test to evaluate the P value of differences between
the French- and German/Italian-speaking parts of Switzerland,
differences were defined as being significant less than a P value
of 0.05. For questions allowing multiple answers, we evaluated
the absolute number as well as percentage (therefore not summing
up to 100).
RESULTS
From October to November 2016, 60 of 66 departments re-
turned the survey, achieving a response rate of 90.1%: PED, n =
12, PICU, n = 5, NICU, n = 6, and multiple departments within
1 hospital under 1 director: NICU/PED (n = 14 2), NICU/PICU
(n = 3 2), andNICU/PICU/PED (n = 1 3). Of 87 respondents,
47 (54.0%) composed 12.4% of all PICU, NICU, and PED spe-
cialists practicing in Switzerland (n = 380) as of January 20,
2017 (see Supplemental Digital Content 3, http://links.lww.com/
PEC/A409). Because neonates may present with different pathol-
ogies than infants and children, we subdivided the respondents
into 2 groups for analysis of IV fluid, BP, TXA, and MTP use:
group A (PED, PICU, n = 17) excluded and group B (n = 30) in-
cluded departments treating neonates. Because of our reminder
style, more than 1 questionnaire was returned from the same
FIGURE 1. Intravenous fluid applied for all types of shock (n = 47 respondents, multiple answers were possible).
TABLE 1. Intravenous Volume Administered According to Type
of Shock
Type of Shock
No.
Observations
IV Volume
Administered, mL/kg
Anaphylactic 40 16.9 (5.63)
Septic 40 18.4 (3.5)
Hemorrhagic 38 19.1 (2.8)
Cardiogenic 42 7.9 (5.0)
Hypovolemic 41 18.5 (3.6)
Hypovolemic (in the
context of DKA)
37 16.5 (5.8)
Neurogenic 36 15.6 (5.7)
Values are mean (SD), unless otherwise indicated.
TABLE 2. Reasons for Choice of Colloids and Crystalloids
A. Reasons for switching to colloids after
initial use of crystalloids
n = 23
Hypoalbuminemia 16 (69.6)
Lack of clinical response 11 (47.8)
After a fixed volume of crystalloids 6 (26.1)
B. Reasons for using colloids rather than crystalloids n = 23
Higher intravascular volume expansion effect 10 (43.5)
Limitations of fluid overload 3 (13.0)
Maintenance of colloid oncotic pressure 12 (52.2)
Preservation of microcirculation 2 (8.7)
Other reasons 4 (17.4)
C. Reasons for using crystalloids rather than colloids n = 47
Costs 20 (42.6)
Impairment of coagulation 10 (21.3)
Risk of renal dysfunction 13 (27.7)
No difference in efficacy 31 (66.0)
Storage/long term effects 6 (12.8)
Risk of virus/prion transmission 7 (14.9)
Other reasons 10 (21.3)
Values are number (percentage).
Groups do not sum up to 100%because multiple answers were possible.
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department in 4 cases. Because not all answers from 1 department
were identical, all questionnaires were included for analysis.
Intravenous Fluid and Volume
Most respondents used NS for shock throughout all age
groups (n = 42/46, 91.3%), whereas BES were administered by
fewer participants (n = 20/46, 43.5%) (Fig. 1). The mean volumes
for diverse shocks ranged from 15.6 to 19.1 mL/kg per bolus; car-
diogenic shockwas treated by smaller volumes (mean = 7.9mL/kg,
range 0–20 mL/kg) (Table 1).
Colloids
Half of participants (n = 23/47, 48.9%) used colloids. The
most common reasons for switching to colloids after crystalloids,
using colloids rather than crystalloids and preferring crystalloids
over colloids, are depicted in Table 2.
Phase of Fluid Resuscitation and Role of
Balanced Solutions
One third of respondents (n = 17/47, 36.2%) chose the fluid
depending on the phase of volume resuscitation. Balanced electro-
lyte solutions were important/very important for the treatment of
pediatric shock in two thirds (n = 29/47, 61.7%), neither important
nor unimportant in one third (n = 13/47, 27.7%), and unimportant/
very unimportant in 10.6% of cases (n = 5/47).
Blood Products
Almost all participants (n = 42/43, 97.7%, do not sum up to
100% as multiple answers were possible) administered packed
red blood cells (RBC) two-third (n = 26/43, 60.5%) thrombocyte
concentrate, 4 in 5 (n = 38/43, 88.4%) fresh frozen plasma (FFP),
and only 1 in 5 (n = 8/43, 18.6%) fibrinogen. Eighteen (41.9%) of
43 subjects also applied BPs for nonhemorrhagic shock (group
A: n = 8/16, 50.0%; group B: 10/27, 37.0%); septic and hypovo-
lemic shock were the most and second most frequent indication
(Tables 3, 4). Thirty-nine percent (n = 17/43) treated severe head
injury (SHI), defined as having glasgow coma scale of less than
9 (group A: n = 10/16, 62.5%; group B: n = 7/27, 25.9%), and
41.2% (n = 7/17) differentiated in their choice of IV fluid de-
pending on whether or not children with shock did or did not
have concomitant SHI (Table 5).
Tranexamic Acid
One in 3 respondents (n = 14/43, 32.6%) administered TXA
for hemorrhagic shock (group A: n = 8/16, 50.0%; group B: n = 6/
27, 22.2%) with quantities ranging from 10 to 25 mg/kg: 10 mg/kg
(n = 2/14, 14.3%), 10 to 15mg/kg (n = 1/14, 7.1%), 15mg/kg (n = 3/
14, 21.4%), 15 to 20 mg/kg (n = 2/14, 14.3%), 20 mg/kg (n = 3/14,
21.4%), and 25 mg/kg (n = 1/14, 7.1%).
Massive Transfusions and Protocols
Half of respondents (n = 22/43, 51.2%) performed massive
transfusions. However, MTPs only existed in 4 departments,
TABLE 3. Type of IV Fluid Administered for Hemorrhagic Shock Before BP Application, Chronologically Classified (n = 47, Missing
Answers: n = 4)
Quick RBCs First choice (n = 47) Second choice (n = 47) Third choice (n = 47)
Quick RBCs 5 (10.6)
NS 28 (59.6) 1 (2.1) 0
FFP 1 (2.1) 6 (12.8) 3 (6.4)
Albumin 0 0 4 (8.5)
LR 4 (8.5) 7 (14.9) 0
RA 2 (4.3) 0 0
RAM 1 (2.1) 2 (4.3) 0
Other 1 (2.1) 0 0
Missing values 5 (10.6)
Applied IV fluids before administration of BP ≥1 IV fluid (n = 37) ≥2 IV fluids (n = 16) ≥3 IV fluids (n = 7)
Values are number (percentage).
TABLE 4. Blood Product Used for Nonhemorrhagic Shock
Type of Shock
BP Used for Nonhemorrhagic
Shock (n = 18)
Group A, BP Used for
Nonhemorrhagic Shock (n =8)
Group B, BP Used for
Nonhemorrhagic Shock (n = 10)
Anaphylactic 1 (5.6) 1 (12.5) 0 (0)
Septic 11 (61.1) 7 (87.5) 4 (40.0)
Cardiogenic 5 (27.8) 4 (50.0) 1 (10.0)
Hypovolemic 9 (50.0) 3 (37.5) 6 (60.0)
Hypovolemic (within context of DKA) 1 (5.6) 1 (12.5) 0 (0)
Neurogenic 1 (5.6) 1 (12.5) 1 (10.0)
Values are number (percentage).
Groups do not sum up because multiple answers were possible.
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primarily in tertiary hospitals (group A: n = 3/16, 18.8%; group B:
n = 1/25, 4%).
Differences Between East and West Switzerland
We observed statistically significant (P < 0.01) differences in
the choice of IV fluid between the French, including bilingual
German-/French-speaking areas (West Switzerland) and German-/
Italian-speaking regions (East Switzerland) (Table 6). West
Switzerland exclusively administered NS to prematurely and
term newborns and to infants and children in 89.5% of cases. In
contrast, only 60.0% (n = 15) of East Switzerland's respondents
exclusively used NS in prematurely and term newborns and
36.4% (n = 8) in infants and children (Table 6).
DISCUSSION
We observed a distinct clinical practice variation regarding
IV fluid administration among Swiss pediatric emergency physi-
cians, pediatric intensivists, and neonatologists. Although pediat-
ric resuscitation guidelines recommend the use of “isotonic
crystalloids,”3 there is growing evidence that BES might be pref-
erable to NS for fluid resuscitation except in case of preexisting
cerebral edema or chloride deficiency.2,13 However, supporting
data mainly stem from the adult population9 and studies in children
are scarce. Our survey reveals this mentioned trend toward the
use of BES, however, with a rift between West Switzerland, still
preferring NS, and East Switzerland, tending to use BES and to
prefer to LR to RA. Although acetate might possess some cardio-
depressant and vasodilator effects, it has advantages over lactate,
stabilizing pH more rapidly and being metabolized in various tis-
sues, whereas lactate is processed predominantly in the liver. Bicar-
bonate, the logical alternative to lactate/acetate, is impracticable
because of storage difficulties and its sensitivity to CO2.
13 Al-
though associated with hyperchloremic metabolic acidosis in
adults,2,5,9 NS is the most frequently used IV fluid in all pediatric
and neonatal age groups across Switzerland. This may be ex-
plained by scarcity of consistent CPGs specifying the choice of
IV fluid. Even if only half of respondents differentiated in the
choice of IV fluid depending on the presence or absence of con-
comitant SHI, these 50% followed the current opinion by using
NS/hypertonic saline for patients at risk for brain edema.13 The
surveyed initial volume administration for shock is in line with
current recommendations,3 that is, administration of 20 mL/kg
of isotonic crystalloid boluses,3 and smaller volumes (5–10
mL/kg) for cardiogenic shock to avoid deterioration of cardiac
failure.14 Hemorrhagic shock and active bleeding require RBC
transfusion not later than after two 20 mL/kg of NS boluses.14
Subsequent fluid administration should be tailored to the individ-
ual with frequent clinical reassessments.3 Aggressive fluid resusci-
tation may be harmful in patients in resource-limited settings,3,16
whereas a faster rate of IV rehydration did not significantly influ-
ence neurologic outcomes in DKA.15 Likewise, the observed col-
loid application is in accordance with current recommendations,
that is, colloid administration for failing preservation of circulation
and intravascular volume expansion in septic shock.17 Administra-
tion of BP for nonhemorrhagic shock has been previously re-
ported11 but stands out against recommendations by the British
and Italian hematology societies not advising to apply BP as intra-
vascular volume expanders but only for active bleeding and ab-
normal coagulation tests.18,19 Only few studies have examined
the ratio of BP administered in children12 and only few MTPs ex-
ist in Switzerland. However, adherence to MTPs did reduce mor-
tality in adults, but further pediatric studies are needed.20–22 We
suggest to implement MTPs in all pediatric institutions to stan-
dardize transfusion processes. Our findings reflect a previously
observed rare use of TXA in acute pediatric trauma23–25 with a
wide range of TXA doses.26 Additional studies are warranted
to define indications for TXA and guidelines for dosage among
children, especially in trauma.26
Limitations of the Study
Mixed PED/PICU/NICU and NICUs (42.5% of respon-
dents) answered for mixed patient groups, including neonates.
We recognize that neonatal patients, however, might require treat-
ment for different pathologies than infants and children. To
TABLE 5. Fluids Used in Case of Concomitant SHI and in Case
of Absence of Concomitant SHI
IV fluids used in case of concomitant SHI (n = 7) n = 7
NS 5 (71.4)
Hypertonic saline 5 (71.4)
RA 0
LR 0
FFP 0
HA 0
Gelatine 0
IV fluids used in case of absence of SHI (n = 7)
NS 4 (57.1)
Hypertonic saline 0
RA 1 (14.3)
LR 3 (42.9)
FFP 2 (28.6)
HA 1 (14.3)
Gelatine 1 (14.3)
Mannitol 0
Values are number (percentage).
Groups do not sum up because multiple answers were possible.
TABLE 6. Differences in Choice of IV Fluid Between West (Including Bilingual Regions) and East Switzerland
NS BES NS or BES P (Fisher Exact)
Prematurely (<37 wk of gestation) and term born infants (<28 d of age) 0.0033
East (n = 25) 15 (60.0) 3 (12.0) 7 (28.0)
West (n = 19) 19 (100) 0 0
Infants (>28 d of age) and children 0.0014
East (n = 22) 8 (36.4) 4 (18.2) 10 (45.5)
West (n = 19) 17 (89.5) 0 2 (10.5)
Values are number (percentage), unless otherwise indicated.
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minimize this bias, we analyzed all not age-specific answers for
groups including and excluding neonatal patients separately. Fur-
thermore, we received diverse answers from the same department
in 4 cases. This, however, demonstrated inconsistent IV fluid ad-
ministration practice within 1 department and underlines the need
for uniform practice guidelines.
CONCLUSIONS
Our study reveals distinct clinical practice variations in IV
fluid resuscitation in pediatric acute care medicine in Switzerland.
Our findings combined with dissention on this topic in the litera-
ture and lack of evidence in children warrant future interventional
studies determining the benefits and adverse effects of various
crystalloids, a better understanding of the pediatric pathophysiol-
ogy, and new fluid compositions based on future study results.13
We suggest the review and implementation of evidence-based
CPG to standardize this frequent intervention, minimize compli-
cations, and ultimately enhance patient safety.
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